Nesfatin-1 mitigates calcium oxalate nephropathy in mice through GPR12 receptor modulation and PKCα/NADPH oxidase pathway inhibition
Fields of Study & Subjects
Kidney Stones and Urolithiasis Treatments
Chronic Kidney Disease and Diabetes
Biomedical Research and Pathophysiology
Publication details
- Journal / source
- Life Sciences
- Publisher
- Elsevier BV
- Volume
- 402
- Pages
- 124544–124544
- Publication date
- 23 June 2026
- Language
- EN